nQ Medical & American Academy of Neurology
Industry Therapeutic Update with Q&A: Digital Cognitive Phenotyping in Neurodegenerative Disease: Modern Metrics for Clinical Science and Practice
Tuesday, April 20, 2021 07:00 PM – 08:00 PM EDT
Addressing the Technology Crisis in Neuropsychiatry presented by Justin Miller, PhD, Director of Neuropsychology, Cleveland Clinic
COBRE Trial: An Exploration of Typing/Touch Tasks in Cognitive Impairment Across the AD presented by Aaron Ritter, MD, Associate Staff, Neuropsychiatry and Behavioral Neurology, Cleveland Clinic
Join us at the conference:
Relevant Resources:
The Digital Race for Early Detection and a Cure, Journal of International Clinical Trials, 2020
Immediate Impact on Efficiencies in Clinical Development of Neurologic Therapeutics, nQ Medical White Paper, 2019
Remote Monitoring of Treatment Response in Parkinson’s Disease: The Habit of Typing on a Computer, Movement Disorders, 2019
To learn more about nQ Medical, please select your area of interest below:
AI/Machine Learning
Decentralized Clinical Trials of Digital Biomarkers
Commercial Applications
nQ Medical | All Rights Reserved
Connect with Richie Bavasso, CEO
Connect with Teresa Arroyo Gallego, PhD, Chief Data Scientist
Connect with Ijah Mondesire-Crump, MD, Vice President, Clinical